Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-25

Clinical Trial Update: Acetazolamide for Obstructive Sleep Apnea to Improve Heart Health [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating acetazolamide for obstructive sleep apnea to improve heart health has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of California, San Diego | Conditions: Obstructive Sleep Apnea | Phase 2 | Status: COMPLETED